Blue Marble Energy and Bionavitas Announce Partnership to Produce Industrial Biochemicals from ...(necessary for cost effective commercial ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Blue Marble Energy and Bionavitas Announce Partnership to Produce Industrial Biochemicals from Microalgae
Date:10/9/2009
necessary for cost effective commercial applications.
More information is available at www.bionavitas.com.
SOURCE Blue Marble Energy Corp.
'/>"/>
| SOURCE Blue Marble Energy Corp. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Blue Marble Energy Corp. Announces Successful Close of Series A Financing
2. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
3. A New Economic Future for Rural Indiana?: Study to Show How Renewable Energy Could Trigger Boom for Economically Struggling Areas in State
4. Energy-autonomous sensors for aircraft
5. Enerkem Announces Unique Community Energy Project
6. New nanostructure technology provides advances in eyeglass, solar energy performance
7. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
8. Fauve Intertrade Signs Major Energy Contracts in China
9. Reject watermelons -- the newest renewable energy source
10. DOE awards $377 million in funding for 46 energy frontier research centers
11. VIASPACE Pursuing Renewable Energy Business in Asia
Post Your Comments:
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3
[0] Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia[0] Marrone Bio Innovations Announces Two New Executive Appointments[0] Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development[0] Dendreon Announces Pricing of Common Stock Offering
Other Biology Technology:James Webb Space Telescope marks successful completion 2Biotech Survives Market Turbulence in November 2Biotech Survives Market Turbulence in November 3Biotech Survives Market Turbulence in November 4Biotech Survives Market Turbulence in November 5
Breaking Biology News(10 mins):University of Washington professor garners Avanti Young Investigator Award 2Princeton scientists find way to catalog all that goes wrong in a cancer cell 2Vermicompost from pig manure grows healthy hibiscus 2China Nepstar Chain Drugstore Announces Management Change 55094 1China Nepstar Chain Drugstore Announces Management Change 55094 2China Nepstar Chain Drugstore Announces Management Change 55094 3FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone 55093 1FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone 55093 2FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone 55093 3Cancer patients who are separated when diagnosed have worse survival rates 55091 1Cancer patients who are separated when diagnosed have worse survival rates 55091 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |